The European Medical Journal Presents: EMJ 3.4 - European Medical Journal

The European Medical Journal Presents: EMJ 3.4

London, United Kingdom, December 13, 2018

Detailing a myriad of fascinating topics inside, the multidisciplinary publication, EMJ 3.4, is now available.

Presenting high-quality peer-reviewed articles that are sure to whet the appetite of individuals from across the field of medicine, the latest edition of the European Medical Journal details topics ranging from the diagnosis and treatment of asthma, to the effect of mesenchymal stem cells in autoimmune arthritis.

The Editor’s Pick for this edition, by Ayers and Nasta, considers the most recent developments in the immunotherapeutic treatment of non-Hodgkin’s lymphoma. Encompassing chimeric antigen receptor T cells, T cell engager antibodies, and immune checkpoint inhibition, this fascinating review highlights the successes and aims to guide future study.

As 2019 rapidly approaches, this publication is sure to push the boundaries of medical science, bringing together fascinating articles providing a springboard for productive discussion within the medical community.

 

Notes to Editors

About EMJ:

Renowned for being the only medical journal to review the biggest European congresses, six weeks after each event is held, the European Medical Journal is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in the field.

Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest from the field within our medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research and review papers from a variety of topics, alongside unique features and interviews. If you’re interested in receiving quarterly newsletters, and the latest publications straight to your inbox, please do subscribe for free: https://www.emjreviews.com/mailing-list/.

If you would like more information about this publication, please call Stacey Rivers at +44 (0) 1245 334450, or email [email protected].

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given